China Anticorruption Investigation’s Leads GSK To Voluntarily Withdraw RDPAC Membership
This article was originally published in PharmAsia News
Executive Summary
No charges have been filed against GSK since an investigation into bribery was launched in July, but the U.K.-based multinational has voluntarily withdrawn its membership from China’s Big Pharma association as the probe continues.